Recently on Axinn Viewpoints – December 13

The Skinny on Infringement of Method of Treatment Claims.? In Hatch-Waxman litigation, method of treatment patents present unique infringement issues. Because generic drug manufacturers typically do not treat patients, patentees frequently allege induced or contributory infringement.?The Federal...?Read more.?

HHS to Go a March-In'.? Following years of discussion and pressure being applied by certain policymakers (including Senate HELP Committee Chair Bernie Sanders), the Biden Administration announced that a framework is being put forward by HHS and the Department of Commerce...?Read more.?

Clarity May Be Around the Corner for Antitrust Scrutiny of Reverse Payment Settlements.? In the ten years since the Supreme Court ruled in Federal Trade Commission v. Actavis that reverse payment settlements—or settlements where a patent holder pays an accused patent infringer cash or other consideration to end the patent...?Read more.?